Assignee
ALBA THERAPEUTICS CORP
US·4 granted patents·20 pending applications·32 citations·filing 2007–2021
Top patents by PatentIndex Score
24 records- 0195US8034776B2Materials and methods for the treatment of celiac diseaseALBA THERAPEUTICS CORP·Filed 2007·Granted Oct 11, 2011·20 cites·11 claims
- 0287US9051349B2Larazotide acetate compositionsALBA THERAPEUTICS CORP·Filed 2013·Granted Jun 9, 2015·8 cites·8 claims
- 0384US11149063B2Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2019·Granted Oct 19, 2021·2 cites·9 claims
- 0478US10526372B2Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2018·Granted Jan 7, 2020·2 cites·14 claims
- 0573US2022009965A1Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0670US2014296165A1Use of tight junction antagonists to treat inflammatory bowel diseaseALBA THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 0770US2021154260A1Formulations for a tight junction effectorALBA THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0865US2008014218A1Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agentsALBA THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 0962US2016349257A1Methods and compositions for the diagnosis of crohn's diseaseALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 1062US2016151449A1Use of tight junction antagonists to treat inflammatory bowel diseaseALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 1160US2014296130A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 1260US2016109444A1Methods and compositions for the diagnosis of crohn's diseaseALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 1359US2015164978A1Formulations for a tight junction effectorALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 1458US2016354426A1Methods of diagnosing and treating asthmaALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 1558US2018133281A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1658US2016375089A1Materials and methods for the treatment of celiac diseaseALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 1757US2016106803A1Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distressALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 1857US2016106802A1Methods of diagnosing and treating asthmaALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 1956US2014294894A1Transcutaneous delivery of therapeutic agentsALBA THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 2055US2014171377A1Novel peptides that enhance tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 2154US2017096451A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2253US2016228488A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2350US2018271932A1Methods of treating celiac disease with larazotideALBA THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 2450US2015203537A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →